Cargando…
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19
This article summarizes the likely attenuation properties of RRx-001 in COVID-19 based on its mechanism of action and the putative pathogenesis of the disease, which appears to activate inflammatory, oxidative, and immune cascades with the potential to culminate in acute respiratory distress syndrom...
Autores principales: | Oronsky, Bryan., Knox, Susan., Cabrales, Pedro., Oronsky, Arnold., Reid, Tony R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341953/ https://www.ncbi.nlm.nih.gov/pubmed/32718560 http://dx.doi.org/10.1053/j.seminoncol.2020.07.002 |
Ejemplares similares
-
RRx-001, A novel dinitroazetidine radiosensitizer
por: Oronsky, Bryan, et al.
Publicado: (2016) -
Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells
por: Oronsky, Bryan, et al.
Publicado: (2018) -
Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx‐001
por: Oronsky, Bryan, et al.
Publicado: (2018) -
COVID-19: desperate times call for desperate measures
por: von Düring, Stephan, et al.
Publicado: (2020) -
Desperate times call for desperate measures
por: Şahin Duyar, Sezgi, et al.
Publicado: (2022)